Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03339258 · ClinicalTrials.gov registry record · Phase 2
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
A Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by San Francisco Veterans Affairs Medical Center.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03339258 is a Phase 2 study of Stress Disorders, Post-Traumatic that is active but no longer recruiting, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 80 participants, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03339258, a Phase 2 study of Stress Disorders, Post-Traumatic, is active but no longer recruiting, sponsored by San Francisco Veterans Affairs Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, double-blind, placebo-controlled trial of doxazosin will assess doxazosin's effectiveness for PTSD nightmares, subjective sleep quality, and non-nightmare PTSD symptoms in adult men and women veterans with full and partial-syndromal PTSD.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Doxazosin Mesylate, Extended Release
Study Locations (1)
California
- San Francisco VA Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2024-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03339258
The ClinicalTrials.gov registry entry for NCT03339258 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (48% lower). The listed sponsor is San Francisco Veterans Affairs Medical Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03339258 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03339258 about?
NCT03339258 is a clinical study titled "A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD". This randomized, double-blind, placebo-controlled trial of doxazosin will assess doxazosin's effectiveness for PTSD nightmares, subjective sleep quality, and non-nightmare PTSD symptoms in adult men and women veterans with full and partial-syndromal PTSD.
What is the current status of trial NCT03339258?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2018-04-15. Estimated completion is 2024-06.
What conditions does trial NCT03339258 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT03339258?
The interventions under investigation include: Placebo (DRUG), Doxazosin Mesylate, Extended Release (DRUG).
Who is sponsoring clinical trial NCT03339258?
This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03339258 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
-
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
RECRUITING · Phase 2
-
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault
COMPLETED · Phase 2
-
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 2
-
Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.